Free Trial

Nutrien (NTR) Stock Forecast & Price Target

Nutrien logo
$44.58 +0.54 (+1.23%)
(As of 12/20/2024 05:45 PM ET)

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
3
Hold
4
Buy
11

Based on 18 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 3 have given a sell rating, 4 have given a hold rating, and 11 have given a buy rating for NTR.

Consensus Price Target

$58.95
32.23% Upside
According to the 18 analysts' twelve-month price targets for Nutrien, the average price target is $58.95. The highest price target for NTR is $75.00, while the lowest price target for NTR is $48.00. The average price target represents a forecasted upside of 32.23% from the current price of $44.58.
Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

Sign Up

NTR Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
12 Buy rating(s)
10 Buy rating(s)
Hold
4 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
8 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$58.95$60.33$62.39$77.65
Forecasted Upside32.23% Upside28.88% Upside32.57% Upside36.04% Upside
Consensus Rating
Hold
Hold
Hold
Hold

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutrien Stock vs. The Competition

TypeNutrienBasic Materials CompaniesS&P 500
Consensus Rating Score
2.44
2.76
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside32.23% Upside138.78% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent NTR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/12/2024Oppenheimer
3 of 5 stars
 Initiated CoverageOutperform$60.00+25.31%
12/10/2024CIBC
3 of 5 stars
 Reiterated RatingOutperformer$60.00 ➝ $55.00+12.45%
12/3/2024Raymond James
4 of 5 stars
S. Hansen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$58.00 ➝ $60.00+25.63%
11/12/2024TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$63.00 ➝ $61.00+29.32%
10/10/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$66.00 ➝ $51.00+4.04%
9/24/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$62.00 ➝ $50.00+5.31%
9/20/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$60.00 ➝ $60.00+25.26%
9/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Samuelson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$69.00 ➝ $53.00+14.99%
8/16/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$68.00 ➝ $55.00+18.69%
8/12/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Outperform ➝ Sector Outperform$66.00 ➝ $59.00+26.96%
8/9/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$80.00 ➝ $75.00+63.58%
8/8/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Rodriguez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$55.00 ➝ $52.00+14.66%
8/2/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/2/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Reduce
6/11/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$56.00 ➝ $55.00+3.33%
4/29/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$60.00 ➝ $66.00+25.59%
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$62.00+17.92%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$66.00+26.36%
2/23/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$58.00 ➝ $48.00-11.36%
1/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+49.31%
11/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
7/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$70.00+5.69%
6/8/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$94.00 ➝ $85.00+44.73%
5/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$70.00 ➝ $60.00-5.30%
3/28/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
1/20/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$87.00 ➝ $86.00+12.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:52 AM ET.


Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien Ltd. recently increased its quarterly dividend from $0.54 to $0.939 per share, reflecting a strong commitment to returning value to shareholders. This increase represents an annualized yield of 8.05%, which is attractive for income-focused investors.
  • The company has a solid market capitalization of approximately $23.67 billion, indicating a stable financial position and the ability to invest in growth opportunities.
  • Despite recent downgrades from several analysts, Nutrien Ltd. has received a consensus rating of "Hold" with a price target around $60.06, suggesting potential for price appreciation from its current trading price of $47.93.
  • Nutrien Ltd. operates through multiple segments, including Retail, Potash, Nitrogen, and Phosphate, which diversifies its revenue streams and reduces dependency on any single market segment.
  • The company reported a revenue of $5.35 billion in its latest quarter, exceeding analysts' expectations, which indicates strong operational performance and demand for its products.

Nutrien
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • Nutrien Ltd. has experienced a decline in its stock price, which has dropped from a 1-year high of $60.87 to its current price of $47.93, indicating potential volatility and investor uncertainty.
  • The company reported a year-over-year revenue decrease of 5.0%, which may signal challenges in maintaining growth and could affect future earnings.
  • Analysts have issued multiple downgrades, with firms like UBS and Goldman Sachs reducing their price targets significantly, which may reflect a bearish outlook on the company's future performance.
  • The dividend payout ratio is notably high at 144.97%, suggesting that the company is paying out more in dividends than it is earning, which could be unsustainable in the long term.
  • With 63.10% of the stock owned by hedge funds and institutional investors, there may be less stability in the stock price due to potential large sell-offs by these entities.

NTR Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $58.95, with a high forecast of $75.00 and a low forecast of $48.00.

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 3 sell ratings, 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.

According to analysts, Nutrien's stock has a predicted upside of 32.23% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 2 downgrades and 1 upgrade by analysts.

Nutrien has been rated by research analysts at CIBC, Oppenheimer, Raymond James, TD Securities, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.


This page (NYSE:NTR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners